Saliva levels of caspase-1, TNF-α, and IFN-γ in primary Sjögren’s syndrome: oral mucosal abnormalities revisited

In the pSjS group, thoseparameters did not show any correlation with disease duration, seropositivity, and smoking.Conclusion: Despite low disease activity, saliva TNF-α and caspase-1 levels were found to be significantly higher in the pSjS group,which may suggest a possible advantage of local anticytokine treatments in selected cases.

📌 3 Key Takeaways

🎯

Objective & Hypothesis:Background/aim: Abnormalities in oral mucosal immunity contribute to complex pathogenesis of primary Sjögren’s syndrome (pSjS).We aimed to measure saliva and serum levels of caspase-1, tumor necrosis factor-alpha (TNF-α) and interferon gamma (IFN-γ) inpatients with pSjS.Materials and methods: We studied 43 pSjS patients fulfilling the AECG criteria and 30 age/sex-matched healthy controls, as wellas 39 rheumatoid arthritis (RA) patients as a disease control group.

📊

Key Findings & Data:The statistical analysis wasperformed using SPSS 19.0.Results: While no significant difference was found in serum measurements, saliva levels of TNF-α and caspase-1 were significantlyhigher in pSjS patients versus healthy controls when using the Mann–Whitney U test.

💡

Conclusion & Impact:In the pSjS group, thoseparameters did not show any correlation with disease duration, seropositivity, and smoking.Conclusion: Despite low disease activity, saliva TNF-α and caspase-1 levels were found to be significantly higher in the pSjS group,which may suggest a possible advantage of local anticytokine treatments in selected cases.

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Abstract

Background/aim: Abnormalities in oral mucosal immunity contribute to complex pathogenesis of primary Sjögren’s syndrome (pSjS).We aimed to measure saliva and serum levels of caspase-1, tumor necrosis factor-alpha (TNF-α) and interferon gamma (IFN-γ) inpatients with pSjS.Materials and methods: We studied 43 pSjS patients fulfilling the AECG criteria and 30 age/sex-matched healthy controls, as wellas 39 rheumatoid arthritis (RA) patients as a disease control group. ESSDAI scores were less than seven in all patients with pSjS,indicating low disease activity. Quantitative analyses were made in serum and whole saliva samples. The statistical analysis wasperformed using SPSS 19.0.Results: While no significant difference was found in serum measurements, saliva levels of TNF-α and caspase-1 were significantlyhigher in pSjS patients versus healthy controls when using the Mann–Whitney U test. On the other hand, in the pSjS group, salivalevels of TNF-α and caspase-1 were also significantly higher compared to the RA group using Student’s t-test. In the pSjS group, thoseparameters did not show any correlation with disease duration, seropositivity, and smoking.Conclusion: Despite low disease activity, saliva TNF-α and caspase-1 levels were found to be significantly higher in the pSjS group,which may suggest a possible advantage of local anticytokine treatments in selected cases.

🔖

Cite This Article

ÖZÇAKA, Ö., ALPÖZ, E., KARABULUT, G., KABASAKAL, Y., KESER, G., GÜCENMEZ, S., KOÇANAOĞULLARI, H., KİTAPÇIOĞLU, G., NALBANTSOY, A. (2022). Saliva levels of caspase-1, TNF-α, and IFN-γ in primary Sjögren’s syndrome: oral mucosal abnormalities revisited. Turkish Journal of Medical Sciences, Cilt: 48 - Sayı: 3, 554–559. https://ajindex.com/articles/610196

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (9)

Baer AN, Hall CJ. Sjögren syndrome. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, editors. Rheumatology, 6th ed. Vol. II. Philadelphia, PA, USA: Mosby Elsevier; 2015. pp. 1131-1143. Fox RI. Sjögren’s syndrome. Lancet 2005; 366: 321-331.
Liao KP, Karlson EW. Classification and epidemiology of rheumatoid arthritis. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, editors. Rheumatology. 6th ed. Vol. I. Philadelphia, PA, USA: Mosby Elsevier, 2015. pp. 691- 697. Szodoray P, Alexy P, Brunz JG, Centolay M, Jonsson R. Circulating cytokines in primary Sjögren’s syndrome determined by a multiplex cytokine array system. Scand J Immunol 2004; 59: 592-599.
Roescher N, Tak PP, Illei GG. Cytokines in Sjögren’s syndrome. Oral Dis 2009; 15: 519-526.
Baldini C, Rossi C, Ferro F, Santini E, Seccia V, Donati V, Solini A. The P2X7 receptor–inflammasome complex has a role in modulating the inflammatory response in primary Sjögren’s syndrome. J Intern Med 2013; 274: 480-489.
Baldini C, Gallo A, Perez P, Mosca M, Alevizos I, Bombardieri S. Saliva as an ideal milieu for emerging diagnostic approaches in primary Sjögren’s syndrome. Clin Exp Rheumatol 2012; 30: 785-790.
Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS et al. European Study Group on Classification Criteria for Sjögren’s syndrome. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554-558.
Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2010; 69: 1580-1588.
Seror R, Ravaud P, Bowman SJ, Baron G, Tzioufas A, Theander E, Gottenberg JE, Bootsma H, Mariette X, Vitali C et al. EULAR Sjögren’s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren’s syndrome. Ann Rheum Dis 2010; 69: 1103-1109. Prevoo ML, van ‘t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44-48.
Yamada A, Arakaki R, Kudo Y, Ishimaru N. Ta